Last update 21 Nov 2024
Dexamethasone Acetate/Clotrimazole
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Baycuten N |
Target |
Mechanism CYP51A1 inhibitors(Cytochrome P450 51 inhibitors), GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC24H31FO6 |
InChIKeyAKUJBENLRBOFTD-RPRRAYFGSA-N |
CAS Registry1177-87-3 |
View All Structures (2)
Related
1
Clinical Trials associated with Dexamethasone Acetate/ClotrimazolePhase 3 Study, Randomized, Double-blind, Parallel to Evaluate Ketoconazole and Betamethasone Dipropionate(Candicort®) Compared to Clotrimazole and Dexamethasone Acetate(Baycuten N®) in Relief of Fungal Infections/Dermatophytosis Symptoms.
100 Clinical Results associated with Dexamethasone Acetate/Clotrimazole
Login to view more data
100 Translational Medicine associated with Dexamethasone Acetate/Clotrimazole
Login to view more data
100 Patents (Medical) associated with Dexamethasone Acetate/Clotrimazole
Login to view more data
7
Literatures (Medical) associated with Dexamethasone Acetate/Clotrimazole08 Apr 1982Die Medizinische Welt
[Baycuten and baycuten SD. Effect and tolerance].
Article
Author: Urbanska, Z ; Wolowa, F ; Polkowska, M
28 Nov 1980Die Medizinische Welt
[Clinical, bacteriological and histological examinations in the utilization of Baycuten cream].
Article
Author: Szarmach, H ; Poniecka, H ; Niczyporuk, W ; Zaremba, A ; Weuta, H ; Wrónski, A ; Trybuła, I
20 Apr 1979ZFA. Zeitschrift fur Allgemeinmedizin
[Baycuten. Management of eczemas, microbial supperinfected eczemas and dermatitides using Baycuten. Multicentric study].
Article
Author: Hesseling, W
100 Deals associated with Dexamethasone Acetate/Clotrimazole
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Erythema | Phase 3 | BR | 11 Jun 2019 | |
| Inflammation | Phase 3 | BR | 11 Jun 2019 | |
| Athletic Injuries | Phase 3 | CA | 31 Oct 2009 | |
| Myalgia | Phase 3 | CA | 31 Oct 2009 | |
| Osteoarthritis, Knee | Phase 3 | CA | 31 Oct 2009 | |
| Rheumatoid Arthritis | Phase 3 | CA | 31 Oct 2009 | |
| Sprains and Strains | Phase 3 | CA | 31 Oct 2009 | |
| Stiffness | Phase 3 | CA | 31 Oct 2009 | |
| Dermatitis, Seborrheic | Phase 1 | BR | 11 Jun 2019 | |
| Eczema, Dyshidrotic | Preclinical | BR | 11 Jun 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free